Paper39014353
Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.
Liu Y and 8 others. J Nanobiotechnology, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation. Papers, record 39014353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39014353
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirolimus | Major topic |
| Gels | Major topic |
| Animals | |
| Rabbits | |
| Humans | |
| Cornea | |
| Rats | |
| Male | |
| Polysaccharides, Bacterial | |
| Nanoparticles | |
| Administration, Ophthalmic | |
| Corneal Neovascularization | |
| Rats, Sprague-Dawley | |
| Viscosity | |
| Drug Delivery Systems | |
| Ophthalmic Solutions | |
| Cell Line | |
| Biological Availability |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. GF22H128127 | Basic Public Welfare Research Project of Zhejiang Province | PubMed | ||
| No. YS2022009 | Special project of Hangzhou Medical College | PubMed | ||
| 2019E10021 | Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province | PubMed | ||
| 2019E10021 | Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province | PubMed | ||
| No. 82000864 | National Natural Science Youth Foundation of China | PubMed | ||
| No. 2021KY648 | Science and Technology Project of Medicine and Health of Zhejiang | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14727933 | The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease. | Am J Cardiovasc Drugs | 2003 | https://conductscience.org/library/papers/14727933 | PubMed |
| 2 | 23716625 | Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23716625 | PubMed |
| 3 | 30924850 | Rapamycin Rescues Endoplasmic Reticulum Stress-Induced Dry Eye Syndrome in Mice. | Invest Ophthalmol Vis Sci | 2019 | https://conductscience.org/library/papers/30924850 | PubMed |
| 4 | 30904549 | A gellan-based fluid gel carrier to enhance topical spray delivery. | Acta Biomater | 2019 | https://conductscience.org/library/papers/30904549 | PubMed |
| 5 | 35461804 | Development of a Thermosensitive In-Situ Gel Formulations of Vancomycin Hydrochloride: Design, Preparation, In Vitro and In Vivo Evaluation. | J Pharm Sci | 2022 | https://conductscience.org/library/papers/35461804 | PubMed |
| 6 | 21330663 | The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21330663 | PubMed |
| 7 | 35538191 | Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole. | Drug Deliv Transl Res | 2022 | https://conductscience.org/library/papers/35538191 | PubMed |
| 8 | 17582643 | Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. | J Control Release | 2007 | https://conductscience.org/library/papers/17582643 | PubMed |
| 9 | 9721433 | Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. | Clin Biochem | 1998 | https://conductscience.org/library/papers/9721433 | PubMed |
| 10 | 33467464 | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents. | Molecules | 2021 | https://conductscience.org/library/papers/33467464 | PubMed |
| 11 | 32420566 | Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization. | J Mater Chem B | 2020 | https://conductscience.org/library/papers/32420566 | PubMed |
| 12 | 33318177 | Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33318177 | PubMed |
| 13 | 21567404 | Role of senescent fibroblasts on alkali-induced corneal neovascularization. | J Cell Physiol | 2012 | https://conductscience.org/library/papers/21567404 | PubMed |
| 14 | 28433750 | Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide. | Eur J Pharm Sci | 2017 | https://conductscience.org/library/papers/28433750 | PubMed |
| 15 | 11165091 | Solubilization of rapamycin. | Int J Pharm | 2001 | https://conductscience.org/library/papers/11165091 | PubMed |
| 16 | 32895514 | Gelling hypotonic polymer solution for extended topical drug delivery to the eye. | Nat Biomed Eng | 2020 | https://conductscience.org/library/papers/32895514 | PubMed |
| 17 | 25667657 | Preparation of a liposomal delivery system and its in vitro release of rapamycin. | Exp Ther Med | 2015 | https://conductscience.org/library/papers/25667657 | PubMed |
| 18 | 25643990 | Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. | Eur J Pharm Biopharm | 2015 | https://conductscience.org/library/papers/25643990 | PubMed |
| 19 | 20202547 | Keratorefractive effect of microwave keratoplasty on human corneas. | J Cataract Refract Surg | 2010 | https://conductscience.org/library/papers/20202547 | PubMed |
| 20 | 12147616 | Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. | Invest Ophthalmol Vis Sci | 2002 | https://conductscience.org/library/papers/12147616 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42835005 | Microsphere-loaded dual-response in situ gel for enhanced ocular drug delivery. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42835005 | PubMed |
| 42564046 | Development and characterization of an injectable thermoresponsive PLGA nanoparticle-loaded in situ gel for sustained exemestane delivery. | Front Oncol | 2026 | https://conductscience.org/library/papers/42564046 | PubMed |
| 42338899 | Ion‑Responsive in situ Gel of Quercetin‑Loaded PEGylated Liposomes for Anti‑inflammatory Treatment of Dry Eye Disease. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42338899 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39014353
GET https://conductscience.org/api/papers/v1/39014353/references?page=2